MODERATOR
Daniel J. Clauw, MD
Associate Dean, Clinical
and Translational Research
Director, Center for the
Advancement of Clinical Research
Director, Chronic Pain
and Fatigue Research Center
Professor, Internal Medicine-Rheumatology
University of Michigan
Ann Arbor, Michigan

PRESENTERS
Lesley M. Arnold, MD
Associate Professor
Director, Women's Health Research Program
University of Cincinnati College of Medicine
Cincinnati, Ohio

P. Murali Doraiswamy, MD
Chief, Division of Biological Psychiatry
Department of Psychiatry
Duke University Medical Center
Durham, North Carolina
Activity Description
Fibromyalgia is a chronic illness associated with a high level of functional disability that translates into a significant burden on both patients and society. Delays in proper diagnosis can lead to years of missed treatment opportunities. It is critical for clinicians to correctly recognize the signs and symptoms of fibromyalgia and differentiate among medical and psychiatric comorbidities. The most effective treatment strategy requires clinicians to develop an individualized treatment approach that considers the patient's fibromyalgia symptoms and severity, level of function and stressors, and presence of medical and psychiatric comorbidities. Long-term management strategies should include optimizing effective treatments to target patient-specific fibromyalgia symptom domains, while minimizing side effects that may impede medication adherence and patient outcomes.

Learning Objectives
At the end of this educational activity, participants should be able to
  1. Summarize the prevalence and clinical presentation of fibromyalgia as a disease state
  2. Explain the importance of early diagnosis and differentiation of comorbid medical and psychiatric conditions
  3. Identify evidence-based pharmacologic and nonpharmacologic approaches to relieve pain and improve the patient's functional ability and quality of life

Register today to participate in this important educational activity!

www.OptumHealthEducation.com
Registration Code BC041008
Thursday, April 10, 2008
12:00–1:00PMET

This activity will be rebroadcast at 3:00PMET
and will be available for enduring credit only.

Or call 1-800-326-9166 to register for Satellite or Telephone.
Your registration will be confirmed via E-mail or fax.

Broadcast via the 
OptumHealth Learning Network

Accreditation Statements/Credit Designation

OptumHealth Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

OptumHealth Education designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for 1 contact hour (0.1 CEU) in states that recognize ACPE.

To receive live credit, you must attend the entire session and complete the evaluation form. Statements of CE Credit will be issued by the University of Florida College of Pharmacy through OptumHealth Education upon successful completion of the activity. (Live–012-999-08-031-L01-P)

To receive enduring credit, you must pass the post-test with a score of at least 70% and complete the evaluation form. Statements of CE Credit will be issued by the University of Florida College of Pharmacy upon proof of successful completion of the activity. (Enduring–012-999-08-031-H01-P)

OptumHealth Education is an approved provider of continuing nursing education by the Utah Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. The participant will be awarded 1 contact hour of credit for attendance and completion of supplemental materials.

OptumHealth Education is approved by the American Psychological Association to sponsor continuing education for psychologists. OptumHealth Education maintains responsibility for this program and its content.

The participant will be awarded 1 contact hour of credit for attendance and completion of supplemental materials.
This activity is cosponsored by OptumHealth Education (formerly i3 CME) and the University of Florida College of Pharmacy.

This activity is supported by an unrestricted educational grant to OptumHealth Education from Pfizer Inc.
This E-mail message is an advertisement.

If you wish to no longer receive our announcements, simply request to be removed from this list.

The information contained in this electronic E-mail transmission and any attachments are intended only for the use of the individual or entity to whom or to which it is addressed, and may contain information that is privileged, confidential and exempt from disclosure under applicable law. If the reader of this communication is not the intended recipient, or the employee or agent responsible for delivering this communication to the intended recipient, you are hereby notified that any dissemination, distribution, copying or disclosure of this communication and any attachment is strictly prohibited. If you have received this transmission in error, please notify the sender immediately by telephone and electronic mail, and delete the original communication and any attachment from any computer, server or other electronic recording or storage device or medium. Receipt by anyone other than the intended recipient is not a waiver of any attorney-client, physician-patient or other privilege. Thank you.

OptumHealth Education
180 Regent Court
Suite 50
State College, PA 16801
MoreInfo@OptumHealthEducation.com